Abstract
New organotin (IV) based on 2-(thiophene-2-yl)acetic acid and 1-H-pyrazole-3-carboxylic acid derivatives 1-ae and 2a-e was prepared and characterized by IR, 1H and 13C NMR spectroscopy. These reactions were carried out under refluxing conditions using CHCl3 / EtOH (3:1) as solvents and 2:1 / 1:1 acid / metal oxide rations. The tin products were recuperated with moderate and good yields (55-85%). The Compounds (1b, 1e and 2e) were screened for their antitumor activities against two human tumor cell lines: HeLa, an epithelial cell from a fatal cervical carcinoma and HEK293, an embryonic kidney tumor. All three materials show an activity in vitro against these cell lines.
Keywords: Synthesis, Tin, Carboxylic acids, Antitumor activities
Letters in Drug Design & Discovery
Title: Synthesis, Characterization by Means of IR, 1H, 13C - NMR and Biological Investigations on New Diorganotin Carboxylic Acid Derivatives
Volume: 7 Issue: 7
Author(s): Abderrahmane Yahyi, Abdelkader Et-Touhami, Rachid Yahyaoui and Rachid Touzani
Affiliation:
Keywords: Synthesis, Tin, Carboxylic acids, Antitumor activities
Abstract: New organotin (IV) based on 2-(thiophene-2-yl)acetic acid and 1-H-pyrazole-3-carboxylic acid derivatives 1-ae and 2a-e was prepared and characterized by IR, 1H and 13C NMR spectroscopy. These reactions were carried out under refluxing conditions using CHCl3 / EtOH (3:1) as solvents and 2:1 / 1:1 acid / metal oxide rations. The tin products were recuperated with moderate and good yields (55-85%). The Compounds (1b, 1e and 2e) were screened for their antitumor activities against two human tumor cell lines: HeLa, an epithelial cell from a fatal cervical carcinoma and HEK293, an embryonic kidney tumor. All three materials show an activity in vitro against these cell lines.
Export Options
About this article
Cite this article as:
Yahyi Abderrahmane, Et-Touhami Abdelkader, Yahyaoui Rachid and Touzani Rachid, Synthesis, Characterization by Means of IR, 1H, 13C - NMR and Biological Investigations on New Diorganotin Carboxylic Acid Derivatives, Letters in Drug Design & Discovery 2010; 7 (7) . https://dx.doi.org/10.2174/157018010791526241
DOI https://dx.doi.org/10.2174/157018010791526241 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biodegradable Nanoparticles: A Recent Approach and Applications
Current Drug Targets Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Current Medicinal Chemistry Development of Doxorubicin Quantification by Reductive Amination
Current Analytical Chemistry Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Current Medicinal Chemistry Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Current Gene Therapy Cancer Stem Cells in Pediatric Brain Tumors
Current Stem Cell Research & Therapy Interferon alpha for Treatment of Chronic Myeloid Leukemia
Current Drug Targets Overview of the Synthesis of Optically Active 3-Amino-2-Hydroxy-4-Phenylbutyric Acids, Key Intermediates for Numerous Bioactive Compounds
Mini-Reviews in Organic Chemistry Macrocyclic Inhibitors of Hsp90
Current Topics in Medicinal Chemistry Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry New Technologies: Non-Hormonal Female Contraception
Current Women`s Health Reviews Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy
Current Cancer Drug Targets Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells
Current Drug Targets Analytical Methods of Bioactive Metabolites Produced by Plants and Microorganisms
Current Pharmaceutical Analysis Cell Proliferation and Cytotoxicity Assays
Current Pharmaceutical Biotechnology Immune Mechanism, Aging, Season and Diseases: Modulatory Role of Melatonin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)